Real-world use of tirzepatide among individuals without evidence of type 2 diabetes: results from the Veradigm® database
Hunter Gibble T, Chinthammit C, Ward JM, et al.
Diabetes Obes Metab. Pub. online 14 Mar 2025.
Leggi
Breaking news
Hematologic cancers among patients with type 2 diabetes prescribed GLP-1 receptor agonists
Ashruf OS, Hundal J, Mushtaq A, et al.
JAMA Netw Open. 2025;8(3):e250802.
Leggi
Continuous ranibizumab via port delivery system vs monthly ranibizumab for treatment of diabetic macular edema: the pagoda randomized clinical trial
Khanani AM, Campochiaro PA, Graff JM, et al.
JAMA Ophthalmol. 2025:e250006.
Leggi
Port delivery system with ranibizumab vs monitoring in nonproliferative diabetic retinopathy without macular edema: the pavilion randomized clinical trial
Pieramici DJ, Awh CC, Chang M, et al.
JAMA Ophthalmol. 2025:e250001.
Leggi
Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: a target trial emulation study
Ju C, Xiong X, Lui DTW, et al.
Diabetes Res Clin Pract. 2025:112082.
Leggi
Differential effects of type 2 diabetes and gestational diabetes on maternal and cord blood adipokines and newborn weight
Gruber BL, Rawal Y, Irabor P, et al.
BMC Pregnancy Childbirth. 2025;25(1):238.
Leggi
Metformin therapy modifies corneal neuroimmune abnormalities in people with type 2 diabetes
Tsoi AT, Sng J, Tummanapalli SS, et al.
Diabetologia. Pub. online 7 Mar 2025.
Leggi
Multivitamins after myocardial infarction in patients with diabetes: a randomized clinical trial
Ujueta F, Lamas GA, Anstrom KJ, et al.
JAMA Intern Med. 2025:e248408.
Leggi
The impact of sodium-glucose cotransporter-2 inhibitors on atrial fibrillation burden in diabetic patients
Kidess GG, Hamza M, Goru R, et al.
Am J Cardiol. Pub. online 7 Mar 2025.
Leggi